Multi-center Phase I clinical study will evaluate the safety and tolerability of a monovalent strain of avian influenza A (H7N9) vaccine delivered intradermally by Vaxxas’ high-density microarray ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback